Oligonucleotides as modulators of cancer gene expression

被引:30
作者
Curcio, LD
Bouffard, DY
Scanlon, KJ
机构
[1] BERLEX BIOSCI, DEPT CANC RES, RICHMOND, CA 94804 USA
[2] CITY HOPE NATL MED CTR, DEPT GEN & ONCOL SURG, DUARTE, CA 91010 USA
关键词
review; oligonucleotide; antisense; ribozyme; triplex; cancer;
D O I
10.1016/S0163-7258(97)00005-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The delineation of gene function has always been an intensive subject of investigations. Recent advances in the synthesis and chemistry of oligonucleotides have now made these molecules important tools to study and identify gene function and regulation. Modulation of gene expression using oligonucleotides has been targeted at different levels of the cellular machinery. Tripler forming oligonucleotides, as well as peptide nucleic acids, have been used to inhibit gene expression at the level of transcription; after binding of these specific oligonucleotides, conformational change of the DNA's helical structure prevents any further DNA/protein interactions necessary for efficient transcription. Gene regulation can also be achieved by targeting the translation of mRNAs. Antisense oligonucleotides have been used to down-regulate mRNA expression by annealing to specific and determined region of an mRNA, thus inhibiting its translation by the cellular machinery. The exact mechanism of this type of inhibition is still under intense investigation and is thought to be related to the activation of RNase H, a ribonuclease that is widely available that can cleave the RNA/DNA duplex, thus making it inactive. Another well-characterized means of interfering with the translation of mRNAs is the use of ribozymes. Ribozymes are small catalytic RNAs that possess both site specificity and cleavage capability for an mRNA substrate, inhibiting any further protein formation. This review describes how these different oligonucleotides can be used to define gene function and discusses in detail their chemical structure, mechanism of action, advantages and disadvantages, and their applications. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:317 / 332
页数:16
相关论文
共 156 条
[41]   RNA CATALYTIC PROPERTIES OF THE MINIMUM (-)STRSV SEQUENCE [J].
HAMPEL, A ;
TRITZ, R .
BIOCHEMISTRY, 1989, 28 (12) :4929-4933
[42]   POLYAMINES FAVOR DNA TRIPLEX FORMATION AT NEUTRAL PH [J].
HAMPEL, KJ ;
CROSSON, P ;
LEE, JS .
BIOCHEMISTRY, 1991, 30 (18) :4455-4459
[43]   PLASMID DIMERIZATION MEDIATED BY TRIPLEX FORMATION BETWEEN POLYPYRIMIDINE POLYPURINE REPEATS [J].
HAMPEL, KJ ;
BURKHOLDER, GD ;
LEE, JS .
BIOCHEMISTRY, 1993, 32 (04) :1072-1077
[44]   INVITRO CLEAVAGE OF HPV16 E6 AND E7 RNA FRAGMENTS BY SYNTHETIC RIBOZYMES AND TRANSCRIBED RIBOZYMES FROM RNA-TRIMMING PLASMIDS [J].
HE, YK ;
LU, CD ;
QI, GR .
FEBS LETTERS, 1993, 322 (01) :21-24
[45]   RATIONAL DESIGN OF SEQUENCE-SPECIFIC ONCOGENE INHIBITORS BASED ON ANTISENSE AND ANTIGEN OLIGONUCLEOTIDES [J].
HELENE, C .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (11) :1466-1471
[46]   A UNIQUE C-MYC-TARGETED TRIPLEX-FORMING OLIGONUCLEOTIDE INHIBITS THE GROWTH OF OVARIAN AND CERVICAL CARCINOMAS IN-VITRO [J].
HELM, CW ;
SHRESTHA, K ;
THOMAS, S ;
SHINGLETON, HM ;
MILLER, DM .
GYNECOLOGIC ONCOLOGY, 1993, 49 (03) :339-343
[48]   BIOLOGIC AND THERAPEUTIC SIGNIFICANCE OF MYB EXPRESSION IN HUMAN-MELANOMA [J].
HIJIYA, N ;
ZHANG, J ;
RATAJCZAK, MZ ;
KANT, JA ;
DERIEL, K ;
HERLYN, M ;
ZON, G ;
GEWIRTZ, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4499-4503
[49]   REVERSION OF MULTIDRUG-RESISTANCE IN THE P-GLYCOPROTEIN-POSITIVE HUMAN PANCREATIC-CELL LINE (EPP85-181RDB) BY INTRODUCTION OF A HAMMERHEAD RIBOZYME [J].
HOLM, PS ;
SCANLON, KJ ;
DIETEL, M .
BRITISH JOURNAL OF CANCER, 1994, 70 (02) :239-243
[50]   Similar cleavage efficiencies of an oligoribonucleotide substrate and an mdr1 mRNA segment by a hammerhead ribozyme [J].
Holm, PS ;
Dietel, M ;
Krupp, G .
GENE, 1995, 167 (1-2) :221-225